NextGenNK

CAMP, a national competence center within Vinnova's research program for biological medicines, is part of the ATMP Sweden initiative. On May 22nd, 2024 the national CAMP-organized ATMP R&D arranged a project meeting at Karolinska Institutet. NextGenNK Directors Hans-Gustaf Ljunggren and Evren Alici participated.

Ashley Moffett, Professor Emerita at the University of Cambridge, UK, was awarded KI’s honorary doctorate for a lifetime of research that has made groundbreaking discoveries concerning the biological mechanisms behind severe conditions associated with pregnancy.

Hans-Gustaf Ljunggren hosted Ashley Moffett at one of the seminars at Karolinska Institutet, where she gave a presentation entitled “From NK cells to pre-eclampsia: the role of the immune system in pregnancy.” 

Karl-Johan Malmberg receives SEK 19 million to investigate how a subset of NK cells so called “adaptive NK cells”, can be targeted against difficult-to-treat cancer.

This year, The Swedish Cancer Society is making an extra investment in clinical studies and has therefore granted 120 million to 10 research projects. One of the scientists receiving funding is cancer-researcher Karl-Johan Malmberg at Karolinska Institutet, part of the steering group of the NextGenNK competence center. 

Evren Alici, co-director of NextGenNK Competence Center was one of the invited speakers at the Advanced Therapies Week, January 16th-19th, Miami, Florida, USA. At the meeting he discussed “Designing optimal clinical trials and clinical operations for advanced therapies”.